UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Broad betacoronavirus neutralization by a stem helix-specific human antibody

Science (American Association for the Advancement of Science), 2021-09, Vol.373 (6559), p.1109-1116

2021

Link zum Volltext

Verfügbarkeit prüfen

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Nature communications, 2020-11, Vol.11 (1), p.5838-5838, Article 5838

2020

Link zum Volltext

Verfügbarkeit prüfen

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

EBioMedicine, 2021-10, Vol.72, p.103595-103595, Article 103595

2021

Link zum Volltext

Verfügbarkeit prüfen

DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A

PloS one, 2010-10, Vol.5 (10), p.e13687

2010

Link zum Volltext

Verfügbarkeit prüfen

Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.967-976

2009

Link zum Volltext

Verfügbarkeit prüfen

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

Frontiers in immunology, 2022-03, Vol.13, p.845969-845969

2022

Link zum Volltext

Verfügbarkeit prüfen

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters

Frontiers in immunology, 2023-10, Vol.14, p.1163159-1163159

2023

Link zum Volltext

Verfügbarkeit prüfen

Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine

Human vaccines & immunotherapeutics, 2020-09, Vol.16 (9), p.2196-2203

2020

Link zum Volltext

Verfügbarkeit prüfen

A High-Throughput Yellow Fever Neutralization Assay

Microbiology spectrum, 2022-06, Vol.10 (3), p.e0254821

2022

Link zum Volltext

Verfügbarkeit prüfen

Antiviral therapy for hepatitis C virus: beyond the standard of care

Viruses, 2010-04, Vol.2 (4), p.826-866

2010

Link zum Volltext

Verfügbarkeit prüfen

Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2′-C-Methylcytidine, the Active Component of Valopicitabine

Antimicrobial Agents and Chemotherapy, 2006-10, Vol.50 (10), p.3444-3446

2006

Link zum Volltext

Verfügbarkeit prüfen

Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin

Biochemical and biophysical research communications, 2006-09, Vol.348 (1), p.139-144

2006

Link zum Volltext

Verfügbarkeit prüfen

Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors

Antimicrobial Agents and Chemotherapy, 2008-09, Vol.52 (9), p.3433-3437

2008

Link zum Volltext

Verfügbarkeit prüfen

YF17D-based vaccines - standing on the shoulders of a giant

European journal of immunology, 2024-04, p.e2250133-e2250133

2024

Link zum Volltext

Verfügbarkeit prüfen

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Nature (London), 2021-02, Vol.590 (7845), p.320-325

2021

Link zum Volltext

Verfügbarkeit prüfen

SeParate: multiway fluorescence-activated droplet sorting based on integration of serial and parallel triaging concepts

Lab on a chip, 2024-03, Vol.24 (7), p.217-2121

2024

Link zum Volltext

Verfügbarkeit prüfen

Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies

Antiviral research, 2023-08, Vol.216, p.105670-105670, Article 105670

2023

Link zum Volltext

Verfügbarkeit prüfen

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect

Antiviral research, 2022-06, Vol.202, p.105311-105311, Article 105311

2022

Link zum Volltext

Verfügbarkeit prüfen

Broad betacoronavirus neutralization by a stem helix–specific human antibody

Science (American Association for the Advancement of Science), 2021-09, Vol.373 (6559)

2021

Link zum Volltext

Verfügbarkeit prüfen

Debio 025, a Cydophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors

Antimicrobial agents and chemotherapy, 2009, Vol.53 (3), p.967-976

2009

Link zum Volltext

Verfügbarkeit prüfen

The Cyclophilin Inhibitor Debio-025 is a Potent Inhibitor of Hepatitis C Virus Replication in vitro With a Unique Resistance Profile

Antiviral research, 2007-06, Vol.74 (3), p.A39-A39

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology and Mechanisms of Action of Antiviral Drugs: Polymerase Inhibitors

Advanced Therapy for Hepatitis C, 2011, p.43-52

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)
Buchkapitel
(1)

Sprache

Englisch
(22)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Broad betacoronavirus neutralization by a stem helix-specific human antibody

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A

Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters

Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine

A High-Throughput Yellow Fever Neutralization Assay

Antiviral therapy for hepatitis C virus: beyond the standard of care

Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2′-C-Methylcytidine, the Active Component of Valopicitabine

Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin

Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors

YF17D-based vaccines - standing on the shoulders of a giant

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

SeParate: multiway fluorescence-activated droplet sorting based on integration of serial and parallel triaging concepts

Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect

Broad betacoronavirus neutralization by a stem helix–specific human antibody

Debio 025, a Cydophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors

The Cyclophilin Inhibitor Debio-025 is a Potent Inhibitor of Hepatitis C Virus Replication in vitro With a Unique Resistance Profile

Pharmacology and Mechanisms of Action of Antiviral Drugs: Polymerase Inhibitors

Suchergebnisse filtern